Daniel Joseph Apel - 15 Apr 2025 Form 3 Insider Report for ARROWHEAD PHARMACEUTICALS, INC. (ARWR)

Role
Chief Financial Officer
Signature
/s/Daniel Joseph Apel
Issuer symbol
ARWR
Transactions as of
15 Apr 2025
Transactions value $
$0
Form type
3
Filing time
12 Aug 2025, 17:49:57 UTC
SEC
View on sec.gov

Reporting Owners (1)

Name Relationship Address Signature Signature date CIK
Apel Daniel Joseph Chief Financial Officer 177 E COLORADO BLVD, SUITE 700, PASADENA /s/Daniel Joseph Apel 12 Aug 2025 0002081169

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
holding ARWR Common Stock 101K 15 Apr 2025 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Includes a total of 100,000 restricted stock units, which will vest over four years.